Pages that link to "Q71079681"
Jump to navigation
Jump to search
The following pages link to Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients (Q71079681):
Displaying 50 items.
- Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells (Q24561962) (← links)
- The "Spot 14" gene resides on the telomeric end of the 11q13 amplicon and is expressed in lipogenic breast cancers: implications for control of tumor metabolism (Q24650555) (← links)
- Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells (Q28178166) (← links)
- Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival (Q28241324) (← links)
- Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis (Q28740280) (← links)
- Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis (Q29615683) (← links)
- Mechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase (Q30589786) (← links)
- Two-site ELISA for the quantitative determination of fatty acid synthase (Q31877198) (← links)
- Overexpression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat. (Q33208958) (← links)
- Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer (Q33287507) (← links)
- Tumor tissue protein signatures reflect histological grade of breast cancer (Q33365644) (← links)
- Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer (Q33421665) (← links)
- Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation (Q33637485) (← links)
- Pathogenesis of ovarian cancer: clues from selected overexpressed genes (Q33651139) (← links)
- Metabolic genes in cancer: their roles in tumor progression and clinical implications (Q33772469) (← links)
- Serum fatty acid synthase as a marker of pancreatic neoplasia (Q33814875) (← links)
- Quercetin induces HepG2 cell apoptosis by inhibiting fatty acid biosynthesis (Q33844220) (← links)
- Inhibition of SREBP1 sensitizes cells to death ligands. (Q33846866) (← links)
- Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology (Q33855476) (← links)
- Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas (Q33865070) (← links)
- Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer (Q33921431) (← links)
- Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma (Q34028928) (← links)
- Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. (Q34058540) (← links)
- HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase (Q34139276) (← links)
- microRNAs and cancer metabolism reprogramming: the paradigm of metformin (Q34357915) (← links)
- Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. (Q34581630) (← links)
- Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells (Q34995485) (← links)
- Synthesis and antitumor activity of an inhibitor of fatty acid synthase (Q35112277) (← links)
- Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma (Q35233688) (← links)
- FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma (Q35556842) (← links)
- Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. (Q35765259) (← links)
- Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women (Q35807962) (← links)
- Modeling cancer metabolism on a genome scale (Q35850350) (← links)
- Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b (Q36062114) (← links)
- Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas (Q36089961) (← links)
- Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase (Q36116027) (← links)
- Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development (Q36177509) (← links)
- Dysregulated lipid metabolism in cancer (Q36198689) (← links)
- Lipidomic approach for stratification of acute myeloid leukemia patients (Q36282427) (← links)
- Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer (Q36355874) (← links)
- Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors (Q36620181) (← links)
- Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production (Q36744130) (← links)
- [(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice (Q36900941) (← links)
- Elovl6 is a poor prognostic predictor in breast cancer (Q37002333) (← links)
- Cohort study of fatty acid synthase expression and patient survival in colon cancer (Q37071671) (← links)
- Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines. (Q37414432) (← links)
- Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. (Q37462773) (← links)
- Human fatty acid synthase: structure and substrate selectivity of the thioesterase domain (Q37595811) (← links)
- Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention (Q37608817) (← links)
- Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer (Q37617965) (← links)